A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer
Authors
Plummer, R.Dean, Emma J
Arkenau, H. T.
Redfern, C.
Spira, A. I.
Melear, J. M.
Chung, K. Y.
Ferrer-Playan, J.
Goddemeier, T.
Locatelli, G.
Dong, J.
Fleuranceau-Morel, P.
Diaz-Padilla, I.
Shapiro, G. I.
Affiliation
Newcastle University and Northern Centre for Cancer Care, Newcastle Hospitals NHS Trust, Newcastle Upon Tyne, United Kingdom.Issue Date
2021
Metadata
Show full item recordCitation
Plummer R, Dean E, Arkenau H-T, Redfern C, Spira AI, Melear JM, et al. A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer Vol. 163, Lung Cancer. Elsevier BV; 2022. p. 19–26.Journal
Lung CancerDOI
10.1016/j.lungcan.2021.11.011PubMed ID
34894455Type
Articleae974a485f413a2113503eed53cd6c53
10.1016/j.lungcan.2021.11.011